Clinical Trial Update: The Safety and Efficacy of TLL-018 in Active Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 trial update on TLL-018 for rheumatoid arthritis reports safety and efficacy data; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• TLL-018

Snippet

Sponsor: Hangzhou Highlightll Pharmaceutical Co., Ltd | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED